Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024
April 03, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
March 27, 2024 08:00 ET
|
LadyBug Resource Group, Inc.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
February 20, 2024 08:38 ET
|
Fractyl Health, Inc.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
US-Based Yes You Can! Appoints New Executive Team to Lead Global Market Expansion
November 04, 2021 16:00 ET
|
Yes You Can!
MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alejandro Chaban, CEO & Founder of health and wellness social networking company Yes You Can! (YYC!), plans to bring awareness of his easy-to-follow...
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
March 12, 2021 19:12 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2020 Financial Results
November 06, 2020 16:45 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Second Quarter 2020 Financial Results
July 30, 2020 06:38 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2020 Financial Results and Business Update
June 19, 2020 06:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
May 11, 2020 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
May 08, 2020 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...